Share this article and save a life!
69% vs 46%. That’s not a typo.
That’s the difference between Epic’s Art AI catching early lung cancer and the national average.
The Christ Hospital in Cincinnati just proved what happens when AI actually works in healthcare: lives saved, not just time.
🔍 Here’s what makes this breakthrough different:
Art doesn’t replace radiologists. It scans every chest X-ray for incidental findings that human eyes might miss during rushed reads. When it spots a potential lung nodule, it automatically adds it to the patient record and schedules the follow-up.
No alerts fatigue.
No workflow disruption.
Just catch cancer when it’s actually treatable.
Over 85% of Epic customers now use Art. Houston Methodist just expanded it to bedside nursing. Home care launches this month.
But here’s what keeps me up at night:
If one AI system can boost detection rates by 50%, what are we missing at hospitals without this technology?
How many cancers go undetected simply because a radiologist had 200 scans to read that day?
The American College of Radiology says workforce shortage is their #1 threat for the third straight year. Meanwhile, imaging demand keeps climbing with our aging population.
This isn’t about AI replacing doctors.
It’s about giving overwhelmed radiologists the tools to save more lives.
The 23% detection gap between AI-enabled and traditional workflows? Those aren’t just statistics. Those are mothers, fathers, friends who get a fighting chance.
Every hospital without this capability needs to ask themselves: can we afford NOT to implement AI that catches cancer this much better?
The technology exists. The results are proven. The only question is implementation speed.
♻️ Repost if early cancer detection shouldn’t depend on your hospital’s tech budget.
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
